Since we did see an effect of anti-PD-L1 treatment on tumor growth and survival in wild-type but not Cblb−/− mice (Figure 3A), we speculated that Cbl-b could play a role in the suppressive PD-1 signaling pathway. The gene discussed is PDCD1; the disease is neoplasm.